
Opinion|Videos|December 6, 2024
BRIDGET Trial: Strategies in Maintenance Therapy for HER2+ Breast Cancer with Brain Metastases
Panelists discuss the progress of the BRIDGET trial and its potential impact on HER2-positive breast cancer patients, focusing on the anticipated data and its implications for treatment strategies in this population.
Advertisement
Episodes in this series

Dr Iyengar: Briefly discuss the BRIDGET trial's progress and the potential impact of its anticipated data on HER2-positive breast cancer patients?
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
TOP Trial: Chemo-Osimertinib in TP53-Mutant EGFR-Mutated NSCLC
2
FLAURA2: Osimertinib Plus Chemo in EGFR-Mutant NSCLC
3
Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance
4
Sequencing CELMoDs With BsAbs and CAR T as a 'Sandwich Strategy' in Multiple Myeloma
5














































































